14-Oct-16 As the Indian government reviews an overhaul of the drug regulatory process, rules related to clinical trials may be further eased and timelines for approvals shortened to 4-6 months from around 6-8 months now. [image: The Economic Times]

06-Oct-16 The medical value travel (MVT) industry is a fast growing segment of India's tourism industry, worth USD3 bn with 15% CAGR. However there is significant potential for accelerated growth. While 11 mn people travelled to seek treatment in 2015, only 500,000 travelled to India. MVT could reach USD9 bn by 2020 and establish India as ‘The provider to the world’. [image: DNA]

05-Oct-16 Giving a push to local production of high-end medical equipment, the Indian government has given its nod to sub-lease over 300 acres of land in Chennai for the country's first medical devices manufacturing park. The project will reduce the dependence on imports and create a strong base for domestic industry by providing access to state-of-the-art infrastructure. [image: PTI]

GGM's 2016 China and Asia-Pacific Ophthalmology market intelligence program subscriptions are now available, giving you access to accurate market data, reliable buyer insights and private custom research topics. Covering Ophthalmology Equipment, IOLs and Hospital Services, the service includes country level data and analysis on: Market opportunities, competitive gaps, surgeon perceptions, installed base, usage, market volume and value size, prices, detailed segmentation, regulations and reimbursement, market players, future outlook, positioning recommendations and more. 

15-Sep-16 Prostate cancer is the second most common cancer among men worldwide. The projection data shows that the number of cases will double by 2020. "With the increased migration of rural population to the urban areas, changing lifestyles, increased awareness, and easy access to medical facility, more cases of prostate cancer are being picked up [in India]," said Dr Kumar, head of Urology at Safdarjang Hospital. [image: The Indian Express]